The Global Market for Clinical Nutrition Products is Projected to Reach US$53.9 Billion by 2020
Aging
Population & Rising Prevalence of Chronic Illnesses Drive the Clinical
Nutrition Products Market, According to a New Report by Global
Industry Analysts, Inc.
GIA announces the release of a
comprehensive global report on Clinical Nutrition Products markets. The
global market for Clinical Nutrition Products is projected to reach US$53.9
billion by 2020, driven by specific nutritional needs of the elderly.
Clinical nutrition is critical for patients who are unable to consume
normal food, as nutritional deficiency caused by the underlying disease
condition enhances the risk of complications, lengthens recovery period, lowers
quality of life, and increases risk of mortality. By providing the required
amounts of essential nutrients such as proteins, vitamins and minerals to
patients, clinical nutrition products aid in improving metabolism, digestion,
absorption, and discharge functions that are critical for normal functioning of
the body. These products are vital for patients in intensive care units,
patients suffering from chronic illnesses, patients recuperating from trauma
and surgeries, and for patients with a high degree of malnourishment. As the
risk of complications is higher in malnourished patients, clinical nutrition
intervention plays a key role in correcting nutritional imbalances.
Malnutrition, if left untreated, could cause a marked decline in physical and
psychological health and function, and also impair recovery from disease and
injury, or surgery. The treatment of disease-related malnutrition with timely
clinical nutrition therapies has been found to reduce mortality and other
complications.
Aging population, increasing incidence of chronic and lifestyle-related
diseases, and shift towards home care, are major factors driving demand in the
market. Rising number of premature births is also spurring demand for medical
products that can meet the nutritional needs of infants. The market is also
benefiting from sustained investments made by manufacturers as well as
government agencies to develop products with improved nutritional attributes.
Technological innovations and automation have made it possible to administer
clinical nutrition therapies at home without the aid of a trained professional.
Also driving growth in the market is the development of lighter and simpler
medical devices used for administering enteral and parenteral nutrition
therapies, in both adults and children. However, stringent regulatory and
reimbursement scenario, need for adequate clinical evidence in support of new
ingredients or products, and the need to comply with safety and quality
standards are hindering growth in the market.
As stated by the new market research report on Clinical Nutrition
Products, the United States represents the largest market worldwide. Asia-Pacific
ranks as the fastest growing market with a CAGR of 11.8% over the analysis
period. Rising life expectancies, growth in the number of disease specific
therapies, heightened awareness about benefits of clinical nutrition, changing
lifestyles, better access to healthcare facilities, and increasing shift
towards home patient care, represent key growth drivers in the region.
Key players covered in the report include Abbott Nutrition, American
HomePatient Inc., Baxter
International Inc., B. Braun Melsungen
AG, Claris Lifesciences Ltd., Groupe Danone, Nutricia North America, Fresenius Kabi AG, Hospira Inc., Mead Johnson Nutrition Company, Meiji Co. Ltd., Nestlé Health Science
S.A, Otsuka Pharmaceutical Factory
Inc., and Sino-Swed Pharmaceutical Corp Ltd., among others.
The research report
titled “Clinical
Nutrition Products: A Global Strategic Business Report” announced by
Global Industry Analysts Inc., provides a comprehensive
analysis of industry segments, trends, growth drivers, market share, market size
and demand forecasts, issues, product launches and other strategic industry activities
of major companies. Geographic regions and
countries analyzed in the report include the United States, Canada,
Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe),
Asia-Pacific (Australia, China, India, and Rest of Asia-Pacific), Middle
East/Africa and Latin America (Brazil, Mexico, and Rest of Latin America).
Product segments analyzed include Enteral Nutrition, Infant Nutrition and
Parenteral Nutrition.
Comments
Post a Comment